News and Info

Welcome to the News and Information section of the ECOG-ACRIN Cancer Research Group website. The materials posted in this section are intended to keep constituents informed of the latest news and activities of the organization. The information below includes press releases, announcements, media advisories, and links to news articles.

We welcome inquiries from members of the press regarding the information posted on this website. To place a media inquiry, contact the Office of Communications.


Latest News

November 21, 2025

The November 2025 News from ECOG-ACRIN blog is now available

November 20, 2025

Guide to SABCS 2025: ECOG-ACRIN research at the world’s largest breast cancer conference

November 18, 2025

Guide to ASH 2025: ECOG-ACRIN and PrECOG are set to reveal multiple blood cancer research discoveries

November 4, 2025

The Fall 2025 advocacy blog, Considering Clinical Trials, is now available

November 3, 2025

STAMP (EA6174), the largest trial of adjuvant pembrolizumab in Merkel cell carcinoma, reports key benefit

October 30, 2025

WATCH: Dr. Janice Mehnert discusses STAMP (EA6174) trial results; adjuvant pembrolizumab in resected Merkel cell carcinoma shows improved distant metastasis-free survival

October 20, 2025

Press Release: Immunotherapy after surgery shows potential in preventing the spread of aggressive skin cancer

October 17, 2025

The October 2025 News from ECOG-ACRIN blog is now available

October 13, 2025

Now Enrolling: STOPGAP II trial opens for patients with stomach cancer

October 13, 2025

Institution Spotlight: Delaware/ChristianaCare NCORP

October 3, 2025

Biomarker breakthroughs at ASTRO 2025 (features a discovery from the E3805 CHAARTED prostate cancer trial)

October 2, 2025

Dr. Xiaolei Shi on validating the APUC-6 signature in metastatic prostate cancer from the E3805 CHAARTED trial

September 22, 2025

The September 2025 News from ECOG-ACRIN blog is now available

September 19, 2025

WATCH: Dr. John Varlotto discusses results from study EA5181 at World Conference on Lung Cancer

September 19, 2025

Now Enrolling: EAA241 trial opens for patients with newly diagnosed multiple myeloma and kidney failure

September 19, 2025

WATCH: Dr. David Gerber discusses E4512 ALCHEMIST trial data at World Conference on Lung Cancer

September 18, 2025

Take Action Today: Rally for Medical Research

September 9, 2025

Dr. Suzanne Cole on using real-world data to improve the generalizability of clinical trial results (highlights PrE1702 and EA5182)

September 8, 2025

EA5181 trial finds no survival benefit for concurrent and consolidative durvalumab vs consolidation alone in unresectable non-small cell lung cancer

August 28, 2025

The August 2025 News from ECOG-ACRIN blog is now available

 
ECOG-ACRIN Cancer Research Group